For 2025, Gentex forecasts $2.4 billion to $2.45 billion in revenue, which would be up from $2.31 billion last year. Analysts polled by FactSet had been projecting $2.58 billion. Write to Dean Seal at ...

Exxon Mobil’s stock gained ground after quarterly profit and free cash flow beat expectations, and production rose, while ...

AbbVie saw fourth-quarter sales handily beat Wall Street's projections as gains from its newer anti-inflammatory drugs helped offset declines from Humira, once its best performing asset. The drugmaker ...

Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...